Apellis Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 33 U.S.-traded ETFs. APLS has around 3.7M shares in the U.S. ETF market. The largest ETF holder of APLS is the iShares Russell 2000 ETF (IWM), with approximately 1.13M shares. Investors may also find of interest that the ETF with the largest allocation to APLS stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 1.59%. On average, U.S. ETFs allocate 0.16% of APLS to their portfolios.
Additionally, APLS is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with APLS as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 35.89%.